Modular Medical, Inc. (MODD) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MODD SEC filings page.
This page shows Modular Medical, Inc. (MODD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Modular Medical remains a financing-supported development business as rising R&D outlays deepen losses and operating cash consumption.
In FY2026, the net loss was$28.2M while operating cash flow was-$23.8M ; the gap reflects noncash and working-capital effects in the earnings-to-cash bridge. After capital spending, free cash flow was-$27.7M , bringing cash economics close to the accounting result rather than indicating broad cash conversion.
R&D investment rose from
FY2026 financing supplied
Financial Health Signals
Modular Medical, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Modular Medical, Inc. passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Modular Medical, Inc. reported a net loss of $28.2M while operations used $23.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Modular Medical, Inc.'s EBITDA was -$6.0M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.6% from the same quarter a year earlier.
Modular Medical, Inc. reported -$6.5M in net income in Q1 2027. This represents an increase of 3.2% from the same quarter a year earlier.
Not reported for Q1 2027.
Cash & Balance Sheet
Modular Medical, Inc. recorded an outflow of $6.7M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 5.6% from the same quarter a year earlier. Against the prior quarter it is up 2.3%.
Modular Medical, Inc. held $3.9M in cash as of Q1 2027; long-term debt is not reported for that period.
Not reported for Q1 2027.
Margins & Returns
Modular Medical, Inc.'s ROE was -60.3% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 3.7 percentage points from the same quarter a year earlier.
Not reported for Q1 2027.
Not reported for Q1 2027.
Not reported for Q1 2027.
Capital Allocation
Modular Medical, Inc. invested $4.4M in research and development in Q1 2027. This represents a decrease of 14.9% from the same quarter a year earlier.
Modular Medical, Inc. invested $688K in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 26.3% from the same quarter a year earlier. Against the prior quarter it is down 31.5%.
Not reported for Q1 2027.
MODD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $4.4M-14.9% | N/A | $5.4M+40.3% | $5.6M+51.1% | $5.1M+60.2% | N/A | $3.9M+0.4% | $3.7M+17.2% |
| SG&A Expenses | $2.2M+29.8% | N/A | $1.8M+83.7% | $2.2M+72.8% | $1.7M+64.5% | N/A | $1.0M-30.0% | $1.3M+25.5% |
| Operating Income | -$6.5M+3.9% | N/A | -$7.2M-49.2% | -$7.8M-56.7% | -$6.8M-61.2% | N/A | -$4.9M+7.9% | -$5.0M-19.2% |
| EBITDA | -$6.0M+5.6% | N/A | -$6.8M-49.0% | -$7.4M-57.1% | -$6.4M-58.9% | N/A | -$4.6M+11.0% | -$4.7M-15.7% |
| Income Tax | N/A | N/A | N/A | $2K0.0% | N/A | N/A | N/A | $2K0.0% |
| Net Income | -$6.5M+3.2% | N/A | -$7.4M-53.2% | -$7.8M-57.2% | -$6.7M-62.0% | N/A | -$4.8M+8.8% | -$5.0M-18.5% |
| EPS (Basic) | -$1.19+67.8% | -$11.99-9891.7% | -$0.11+15.4% | -$0.140.0% | -$3.70-2983.3% | -$0.12+14.3% | -$0.13+43.5% | -$0.14+26.3% |
| EPS (Diluted) | -$1.19 | -$11.99 | -$0.11 | -$0.14 | -$3.70 | -$0.12+14.3% | -$0.13 | -$0.14 |
| Diluted Shares (Avg) | 5M | N/A | 66M | 56M | 2M | N/A | 38M | 34M |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense.
MODD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.3M-13.5% | $14.8M-20.8% | $10.3M-15.6% | $13.0M+47.9% | $14.2M+40.7% | $18.7M+35.7% | $12.1M+96.0% | $8.8M-12.8% |
| Current Assets | $4.8M-41.6% | $7.5M-44.2% | $3.5M-52.7% | $5.9M+42.4% | $8.3M+53.4% | $13.5M+39.4% | $7.3M+213.0% | $4.2M-35.4% |
| Cash & Equivalents | $3.9M-47.9% | $6.9M-47.0% | $2.9M-58.0% | $5.3M+36.6% | $7.5M+48.9% | $13.1M+41.8% | $7.0M+241.3% | $3.9M-38.5% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.5M-36.0% | $1.9M+13.0% | $4.4M+132.0% | $4.2M+126.7% | $2.3M+13.2% | $1.7M-27.0% | $1.9M-19.8% | $1.9M-12.5% |
| Current Liabilities | $1.5M-27.4% | $1.9M+48.1% | $2.2M+57.6% | $4.0M+225.1% | $2.0M+52.8% | $1.3M-13.1% | $1.4M-3.9% | $1.2M+11.9% |
| Non-Current Liabilities | $0-100.0% | $0-100.0% | $2.2M+336.3% | $161K-73.6% | $278K-61.1% | $393K-51.9% | $504K-44.9% | $611K-39.4% |
| Total Equity | $10.8M-9.1% | $13.0M-24.1% | $5.9M-42.7% | $8.8M+26.8% | $11.8M+47.7% | $17.1M+48.0% | $10.3M+166.9% | $6.9M-12.9% |
| Retained Earnings | -$119.5M-30.6% | -$113.0M-33.3% | -$106.6M-33.5% | -$99.2M-32.3% | -$91.5M-30.5% | -$84.8M-28.6% | -$79.8M-29.5% | -$75.0M-33.1% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
MODD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$6.0M-11.2% | -$5.8M-34.9% | -$7.2M-74.7% | -$5.4M-43.7% | -$5.4M-51.4% | -$4.3M-23.0% | -$4.1M-3.3% | -$3.8M-14.9% |
| Depreciation & Amortization | $501K+22.2% | $441K+35.3% | $430K+53.0% | $391K+50.4% | $410K+109.2% | $326K+128.0% | $281K+116.2% | $260K+173.7% |
| Stock-Based Compensation | $447K-38.3% | N/A | $2K-60.0% | $4K-55.6% | $724K+35.3% | N/A | $5K-54.5% | $9K+28.6% |
| Capital Expenditures | $688K-26.3% | $1.0M+6.0% | $1.2M+125.5% | $771K+378.9% | $934K+10.9% | $948K+96.3% | $542K+8.6% | $161K-53.3% |
| Free Cash Flow | -$6.7M-5.6% | -$6.8M-29.7% | -$8.4M-80.6% | -$6.2M-57.4% | -$6.3M-43.6% | -$5.3M-31.9% | -$4.6M-3.9% | -$3.9M-8.4% |
| Investing Cash Flow | -$688K+26.3% | -$1.0M-6.0% | -$1.2M-125.5% | -$771K-378.9% | -$934K-10.9% | -$948K-96.3% | -$542K-8.6% | -$161K+53.3% |
| Financing Cash Flow | $3.6M+396.3% | $10.8M-4.8% | $6.0M-22.4% | $4.0M+43.6% | $733K+249.0% | $11.4M+1.8% | $7.7M+4171.3% | $2.8M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
MODD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | -60.3%-3.7pp | N/A | -125.2%-78.3pp | -88.8%-17.2pp | -56.6%-5.0pp | N/A | -46.8%+90.2pp | -71.7%-19.0pp |
| Return on Assets | -52.9%-5.6pp | N/A | -71.7%-32.2pp | -60.0%-3.5pp | -47.3%-6.2pp | N/A | -39.5%+45.5pp | -56.5%-14.9pp |
| Current Ratio | 3.25-0.8x | 4.03-6.7x | 1.59-3.7x | 1.47-1.9x | 4.040.0x | 10.69+4.0x | 5.30+3.7x | 3.36-2.5x |
| Debt-to-Equity | 0.14-0.1x | 0.140.0x | 0.74+0.6x | 0.48+0.2x | 0.20-0.1x | 0.10-0.1x | 0.18-0.4x | 0.270.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Modular Medical, Inc. MODD | FY2026 | N/A | -$28.2M | N/A | $16.5M | — |
| electroCore, Inc. ECOR | FY2025 | $32.0M | -$14.0M | -43.6% | $93.0M | 45/100 |
| NeuroOne Medical Technologies Corporation NMTC | FY2025 | $9.1M | -$3.6M | -39.6% | $9.0M | 64/100 |
| Inspira Technologies Oxy B.H.N. Ltd. IINN | FY2025 | $289K | -$13.2M | N/A | $16.2M | — |
| Myomo Inc. MYO | FY2025 | $40.9M | -$15.6M | -38.1% | $63.8M | 44/100 |
| VICARIOUS SRGCL INC A RBOT | FY2025 | N/A | -$50.2M | N/A | $13.7M | — |
Where Modular Medical, Inc. Ranks
Frequently Asked Questions
Is Modular Medical, Inc. profitable?
No, Modular Medical, Inc. (MODD) reported a net income of -$28.2M in fiscal year 2026.
What is Modular Medical, Inc.'s EBITDA?
Modular Medical, Inc. (MODD) had EBITDA of -$25.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Modular Medical, Inc.'s return on equity (ROE)?
Modular Medical, Inc. (MODD) has a return on equity of -217.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Modular Medical, Inc.'s free cash flow?
Modular Medical, Inc. (MODD) recorded an outflow of $27.7M in free cash flow during fiscal year 2026. This represents a -52.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Modular Medical, Inc.'s operating cash flow?
Modular Medical, Inc. (MODD) recorded an outflow of $23.8M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
What are Modular Medical, Inc.'s total assets?
Modular Medical, Inc. (MODD) had $14.8M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Modular Medical, Inc.'s capital expenditures?
Modular Medical, Inc. (MODD) invested $3.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Modular Medical, Inc. spend on research and development?
Modular Medical, Inc. (MODD) invested $20.0M in research and development during fiscal year 2026.
What is Modular Medical, Inc.'s current ratio?
Modular Medical, Inc. (MODD) had a current ratio of 4.03 as of fiscal year 2026, which is generally considered healthy.
What is Modular Medical, Inc.'s debt-to-equity ratio?
Modular Medical, Inc. (MODD) had a debt-to-equity ratio of 0.14 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Modular Medical, Inc.'s return on assets (ROA)?
Modular Medical, Inc. (MODD) had a return on assets of -190.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Modular Medical, Inc.'s P/E ratio?
Modular Medical, Inc. (MODD) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $16.5M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Modular Medical, Inc.'s price-to-sales ratio?
Modular Medical, Inc. (MODD) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $16.5M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Modular Medical, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2026, Modular Medical, Inc. (MODD) held $6.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $23.8M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Modular Medical, Inc.'s Piotroski F-Score?
Modular Medical, Inc. (MODD) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Modular Medical, Inc.'s earnings high quality?
Modular Medical, Inc. (MODD) reported a net loss of $28.2M while operations used $23.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.